AMRI makes three promotions AMRI makes three promotions To strengthen sales operations in US and Europe Bausch + Lomb names global president, pharmaceuticals Bausch + Lomb names global president, pharmaceuticals Daniel Wechsler joins from Merck & Co KCAS expands ligand binding assay team KCAS expands ligand binding assay team Proveen Dass joins the company as associate director Pevion Biotech hires new ceo Pevion Biotech hires new ceo Also secures CHF10m of financing Cresset expands sales team Cresset expands sales team Aims to increase its presence in European and US markets in 2011 GSK announces succession plan for cfo GSK announces succession plan for cfo Simon Dingemans joins from Goldman Sachs Lord Lieutenant presents 2010 Queen’s Award to Malvern Instruments Lord Lieutenant presents 2010 Queen’s Award to Malvern Instruments Tribute to technological innovation in Zetasizer Nano particle characterisation systems PharmaVentures appoints senior director PharmaVentures appoints senior director Paul Phull will develop corporate advisory business Tim Edwards becomes chairman of BIA in UK Tim Edwards becomes chairman of BIA in UK Chief executive of Cellzome succeeds Dr Clive Dix Theratechnologies appoints new ceo Theratechnologies appoints new ceo John-Michel Huss has more than 20 years’ experience in the pharmaceutical industry One Nucleus announces new director One Nucleus announces new director Industry expert to support life sciences membership group Vetter opens new US sales office Vetter opens new US sales office To be managed by Troy Carpenter Allen Coding appoints Asia specialist Allen Coding appoints Asia specialist Eric Chan to expand presence of UK firm in the region American Peptide Company appoints two American Peptide Company appoints two Reflects ongoing commitment to provide better customer support New managing director for Adept Scientific New managing director for Adept Scientific Mike Pisapia takes over from co-founder Paul Bragg who becomes chairman Amarin names Colin Stewart as president and ceo Amarin names Colin Stewart as president and ceo Has been in the pharmaceutical industry for more than 30 years